My area of professional expertise is automation of the medium-voltage power distribution grid.. My interest as a private investor is focused mostly on the emerging technologies of start-up pharmaceutical companies. I also try to be as well-informed as possible on overall economic and market trends. In the first six years of my career I worked in drug research at Stanford Medical School looking for non-addictive opiate narcotics. That was long ago; a year before endorphins were discovered. In my present work and for the last 30+ years I have worked in software design for industrial control systems and now both architect and lead major projects to develop next generation control products for the electric power grid.